Nutraveris
Thursday, January 18, 2018

Caffeine attenuates the sprint performance decrement in athletes with low caffeine consumption.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

The aims of this randomized, double-blind study were to investigate the effect of acute ingestion of caffeinated chewing gum on repeated sprint performance in team sport athletes, and whether habitual caffeine consumption alters the ergogenic effect on repeated sprint performance. Eighteen male team sports athletes undertook four repeated sprint performance trials using a 40 m maximum shuttle run test. Each participant completed two sessions, followed by caffeine (CAF; caffeinated chewing gum; 200 mg caffeine) and placebo (PLA; placebo chewing gum) trials. Repeated sprint performance, assessed by sprint performance decrement, did not differ between CAF (5.00±2.84%) and PLA (5.43±2.68%).

Secondary analysis revealed that low habitual caffeine consumers (<40 mg/day, n=10) experienced an attenuation of sprint performance decrement during CAF relative to PLA (5.53±3.12% vs. 6.53±2.91%, respectively; p=0.049, ES=0.33).

 

Sprint performance and caffeine

Sprint performance decrement (%) during the 40 m maximum shuttle run test for placebo (PLA) and caffeine (CAF) trials for participants stratified based on low habitual caffeine consumption. * significant difference at p<0.05.

 

The data suggest that a low dose of caffeine in the form of caffeinated chewing gum attenuates the sprint performance decrement during repeated sprint performance by team sport athletes with low habitual consumption of caffeine.

Evans M, Tierney P, Gray N, Hawe G, Macken M, Egan B. Acute Ingestion of Caffeinated Chewing Gum Improves Repeated Sprint Performance of Team Sports Athletes With Low Habitual Caffeine Consumption. Int J Sport Nutr Exerc Metab. 2017 Nov 1:1-25.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Tuesday, January 16, 2018

Quince fruit consumption significantly reduces nausea and vomiting in pregnant women in comparison with vitamin B6.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

This trial was performed to compare quince fruit consumption (Cydonia oblonga) with vitamin B6 on 76 pregnant women with a gestational age of 6–14 weeks and mild-to-moderate nausea and vomiting.

 

Quince fruit

The quince syrup (1 tablespoon/three times a day, n=40) or vitamin B6 tablets (20 mg/three times a day, n=36) were used as intervention for 1 week. The score of the “Pregnancy-Unique Quantification of Emesis” was decreased from 9.5 (± 2) at baseline to 5.2 (±2.3) on the 7th day and 5.3 (±2.6) on the 14th day (p < 0.001) in the quince group. In the other group, the scores were 8.4 (±1.8), 7.3 (±2.4) and 7.7 (±3.8), respectively (p = 0.001).

The change in symptoms were more marked in the quince group (p < 0.001).

The results of this study demonstrated the significant efficacy of quince in comparison with vitamin B6 and its safety, in the treatment of mild-to-moderate nausea and vomiting in pregnant women.

 

Jafari-Dehkordi E, Hashem-Dabaghian F, Aliasl F, Aliasl J, Taghavi-Shirazi M, Sadeghpour O, Sohrabvand F, Minaei B, Ghods R. Comparison of quince with vitamin B6 for treatment of nausea and vomiting in pregnancy: a randomised clinical trial. J Obstet Gynaecol. 2017 Nov;37(8):1048-1052.

 

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Monday, January 15, 2018

Best wishes 2018 from Nutraveris

Best wishes 2018 from Nutraveris

Thursday, January 11, 2018

Systematic review of adverse effects of caffeine consumption.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:

 

Caffeine is frequently used in food supplements for its beneficial effects on attention and fatigue.

However, there are only few reviews of its adverse effects. The aim of this systematic review was to assess the potential adverse effects of caffeine consumption in healthy subjects, pregnant women, adolescents and children.

caffeine consumption

The evidence generally supports that consumption of up to 400 mg caffeine/day in healthy adults is not associated with overt, adverse cardiovascular effects, behavioral effects, reproductive and developmental effects, acute effects, or bone status.

Evidence also supports consumption of up to 300 mg caffeine/day in healthy pregnant women as an intake that is generally not associated with adverse reproductive and developmental effects.

Limited data were identified for child and adolescent populations. The authors recommend an intake of 2.5 mg caffeine/kg bw/day for adolescents and children.

 

This systematic review confirms therefore the work performed in 2015 by the European Food Safety Authority. Based on these independent results, the consumption of 4 to 5 coffee per day doesn’t represent any risk for healthy adults.

 

 

Wikoff D, Welsh BT, Henderson R, Brorby GP, Britt J, Myers E, Goldberger J, Lieberman HR, O’Brien C, Peck J, Tenenbein M, Weaver C, Harvey S, Urban J, Doepker C. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol. 2017 Nov;109(Pt 1):585-648.

 

This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Scientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Monday, January 8, 2018

Novel foods: a new success for Nutraveris.

Thanks to its substantial experience in the novel food process and management in Europe, Nutraveris has just obtained a new success further to the recognition by the European Food Safety Authority (EFSA) that the orthosilicic acid-vanillin complex (OSA-VC) is safe for human consumption.

EFSA’s opinion comes after a complete evaluation of the application in accordance with the previous novel food regulation (regulation (EC) No 258/97). The ingredient, a dietary source of silicon, has been evaluated by Member States and by EFSA, with deep and important discussions on all the aspects of a novel food application (i.e. characterization of the ingredient, bioavailability and safety).

efsa

 

This new success for Nutraveris confirms its position as a leading consultancy in the European novel food approval.

Nutraveris has indeed all the skills and experience to obtain EU authorizations.

 

Do not hesitate to contact our Scientific & Regulatory experts for further information at NUTRAVERIS

Hotline Nutraveris: +33 2 96 76 54 87 , contact@nutraveris.com

 

Page 1/11112345...102030...Last »